相关实验视频

Updated: Sep 11, 2025

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

营养和免疫-炎症评分系统用于预测新诊断的扩散性大B细胞淋巴瘤患者的结果

Yu Peng¹, Tingting Jiang¹, Shuang Chen¹

¹Chongqing Key Laboratory for the Mechanism and Intervention of Cancer Metastasis, Department of Hematology-Oncology, Chongqing University Cancer Hospital, Chongqing, China.

Frontiers in nutrition

|August 12, 2025

概括

一个新的营养和免疫-炎症评分系统 (NII) 改善了扩散大B细胞淋巴瘤 (DLBCL) 患者的预后预测. 该工具集成了关键标记,以识别高风险个体,帮助个性化治疗策略.

科学领域:

血液学血液学血液学
在瘤学瘤学.
临床研究临床研究

背景情况:

扩散性大B细胞淋巴瘤 (DLBCL) 是一种具有可变预后的侵袭性非霍奇金淋巴瘤.
当前的预后指数 (IPI,NCCN-IPI) 不考虑营养,免疫或炎症状况.
这些因素显著影响DLBCL患者的治疗结果.

研究的目的:

开发和验证一种新的评分系统,包括营养,免疫和炎症标志物,用于DLBCL预后.
评估新系统与现有指数的独立和联合预测价值.

主要方法:

对423名新诊断的DLBCL患者进行了回顾性分析.
使用LASSO-Cox回归的营养和免疫炎症评分系统 (NII) 的开发.
使用培训和验证集以及考克斯回归分析验证NII.

主要成果:

在NII中包含了NRS2002,GNRI,SII,LAR,β2-MG和CD8+ T细胞等标记物.
高NII分数 (≥6) 独立地识别高风险DLBCL患者.
将NII与IPI或NCCN-IPI结合起来,显著改善了预后评估.

结论:

尼伊是一个简单而有效的工具,用于提高DLBCL的预后准确性.
它通过整合易于获得的标记来补充现有的评分系统.
NII有助于早期识别高风险患者,以提供个性化治疗.

关键词:

DLBCL DLBCL 是一个字母.免疫系统是免疫系统的.这是一种炎症性炎症.营养上的营养价值.评分系统评分系统

更多相关视频

Author Spotlight: Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment

Author Spotlight: Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment

Published on: June 2, 2023

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

相关概念视频

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...